- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Immune checkpoint inhibitor-induced diarrhea and colitis: an overview ; volume:32 ; number:10 ; day:23 ; month:9 ; year:2024 ; pages:1-10 ; date:10.2024
Supportive care in cancer ; 32, Heft 10 (23.9.2024), 1-10, 10.2024
- Creator
-
Zoghbi, Marianne
Burk, Kathryn J.
Haroun, Elio
Saade, Maria
Carreras, Maria Teresa Cruz
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-024-08889-2
- URN
-
urn:nbn:de:101:1-2501082102031.093826086592
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zoghbi, Marianne
- Burk, Kathryn J.
- Haroun, Elio
- Saade, Maria
- Carreras, Maria Teresa Cruz
- SpringerLink (Online service)
Other Objects (12)
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis
Diffuse Metastatic Melanoma in the GI Lumen Following Immune Checkpoint Inhibitor Colitis Treatment
Severe Inflammatory Colitis Related to Encorafenib and Binimetinib following Immune Checkpoint Inhibitor Therapy
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis
Primary eosinophilic colitis as an unusual cause of chronic diarrhea
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis
Diffuse Metastatic Melanoma in the GI Lumen Following Immune Checkpoint Inhibitor Colitis Treatment
Severe Inflammatory Colitis Related to Encorafenib and Binimetinib following Immune Checkpoint Inhibitor Therapy
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis
Primary eosinophilic colitis as an unusual cause of chronic diarrhea
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis
Diffuse Metastatic Melanoma in the GI Lumen Following Immune Checkpoint Inhibitor Colitis Treatment
Severe Inflammatory Colitis Related to Encorafenib and Binimetinib following Immune Checkpoint Inhibitor Therapy
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis
Primary eosinophilic colitis as an unusual cause of chronic diarrhea